In: Nursing
Human papillomavirus (HPV) infection is perhaps the most common STI in the United States and certain types of HPV cause cervical, anal, penile, and throat cancers. Vaccine against certain HPV types are now available and recommended for adolescent boys and girls. Discuss the concerns regarding the vaccine that have contributed to low uptake of HPV vaccine among U.S. adolescents?
Introduction:
HPV is Human Papilloma Virus can cause cervical, vulvar, and vaginal cancers in women and penile cancer in men. It can also cause anal cancer, throat cancer and genital warts in both men and women.
HPV vaccine are given for preteen boys and girls aged 11 or 12 years, so they are protected before being exposed to the virus and also to the adolescent aged groups. Two vaccines (Cervarix and Gardasil) protect against cervical cancers in women. Gardasil also protects against genital warts and cancers of the anus, vagina, and vulva. Both vaccines are available for females; only Gardasil is available for males. HPV vaccines are given as a series of three shots over six months.
The concerns regarding the vaccine that have contributed to low uptake of HPV vaccine among U.S. adolescents are:
Perceived barriers to vaccination are categorized as: